BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garmpis N, Damaskos C, Garmpi A, Georgakopoulou VE, Sarantis P, Antoniou EA, Karamouzis MV, Nonni A, Schizas D, Diamantis E, Koustas E, Farmaki P, Syllaios A, Patsouras A, Kontzoglou K, Trakas N, Dimitroulis D. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. J Pers Med 2021;11:223. [PMID: 33809844 DOI: 10.3390/jpm11030223] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Sartorius K, Antwi SO, Chuturgoon A, Roberts LR, Kramvis A. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality? Front Oncol 2022;12:891812. [PMID: 35600358 DOI: 10.3389/fonc.2022.891812] [Reference Citation Analysis]
2 Damaskos C, Garmpis N, Dimitroulis D, Garmpi A, Diamantis E, Sarantis P, Georgakopoulou VE, Patsouras A, Despotidis M, Prevezanos D, Syllaios A, Marinos G, Koustas E, Vallilas C, Antoniou EA, Kontzoglou K, Savvanis S, Kouraklis G. The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma. JPM 2022;12:753. [DOI: 10.3390/jpm12050753] [Reference Citation Analysis]
3 Bär SI, Dittmer A, Nitzsche B, Ter-Avetisyan G, Fähling M, Klefenz A, Kaps L, Biersack B, Schobert R, Höpfner M. Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer. Int J Oncol 2022;60:73. [PMID: 35485292 DOI: 10.3892/ijo.2022.5363] [Reference Citation Analysis]
4 Reddy D, Bhattacharya S, Shah S, Rashid M, Gupta S. DNA methylation mediated downregulation of histone H3 variant H3.3 affects cell proliferation contributing to the development of HCC. Biochim Biophys Acta Mol Basis Dis 2022;1868:166284. [PMID: 34626773 DOI: 10.1016/j.bbadis.2021.166284] [Reference Citation Analysis]
5 Leone P, Solimando AG, Fasano R, Argentiero A, Malerba E, Buonavoglia A, Lupo LG, De Re V, Silvestris N, Racanelli V. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment. Vaccines (Basel) 2021;9:532. [PMID: 34065489 DOI: 10.3390/vaccines9050532] [Reference Citation Analysis]